Purpose: Acquisition timing and B 1 calibration are two key factors that affect the quality and accuracy of hyperpolarized 13 C MRI. The goal of this project was to develop a new approach using regional bolus tracking to trigger Bloch-Siegert B 1 mapping and real-time B 1 calibration based on regional B 1 measurements, followed by dynamic imaging of hyperpolarized 13 C metabolites in vivo.
Purpose: Acquisition timing and B 1 calibration are two key factors that affect the quality and accuracy of hyperpolarized 13 C MRI. The goal of this project was to develop a new approach using regional bolus tracking to trigger Bloch-Siegert B 1 mapping and real-time B 1 calibration based on regional B 1 measurements, followed by dynamic imaging of hyperpolarized 13 C metabolites in vivo.
Methods:
The proposed approach was implemented on a system which allows realtime data processing and real-time control on the sequence. Real-time center frequency calibration upon the bolus arrival was also added. The feasibility of applying the proposed framework for in vivo hyperpolarized 13 C imaging was tested on healthy rats, tumor-bearing mice and a healthy volunteer on a clinical 3T scanner following hyperpolarized [1- 13 C]pyruvate injection. Multichannel receive coils were used in the human study. Results: Automatic acquisition timing based on either regional bolus peak or bolus arrival was achieved with the proposed framework. Reduced blurring artifacts in real-time reconstructed images were observed with real-time center frequency calibration. Real-time computed B 1 scaling factors agreed with real-time acquired B 1 maps. Flip angle correction using B 1 maps results in a more consistent quantification of metabolic activity (i.e, pyruvate-to-lactate conversion, k PL ). Experiment record-
ings are provided to demonstrate the real-time actions during the experiment.
Conclusions:
The proposed method was successfully demonstrated on animals and a human volunteer, and is anticipated to improve the efficient use of the hyperpolarized signal as well as the accuracy and robustness of hyperpolarized 13 C imaging.
and fast decay of the hyperpolarized magnetization, acquisition timing and transmit power (B 1 ) calibration are two key factors that affect the quality and accuracy of hyperpolarized 13 C imaging.
Bolus tracking for triggering the acquisition has been used in clinical MRI for proton MR angiography.
14 Appropriate acquisition timing for hyperpolarized 13 C imaging is useful in several aspects: (a) Excitation before the bolus arrival may saturate the nonrecoverable hyperpolarized signal particularly near the coils conductive elements where the B 1 can be elevated. (b) Many variable flip schemes [15] [16] [17] [18] that optimize the hyperpolarized MRI signal sampling require knowledge of the bolus arrival. (c) It is more straightforward for kinetic modeling to start signal sampling after the bolus maximum 19 to eliminate the need to account for the input function. (d) Inconsistent acquisition timing leads to quantification errors when metabolite to substrate ratios are used as a quantitative metric. 19, 20 Currently, in vivo hyperpoliarized 13 C imaging protocols typically start at a certain delay time after bolus injection. The delay time is determined based on prior knowledge, which can be unreliable due to the inherent physiological variability of each individual. This is particularly problematic in human subjects in which 12 s variations in bolus arrival have been observed. 11 This variability can be further exacerbated in tumors where the vascularization and perfusion are highly inconsistent over subjects. 21 Recently, a bolus tracking method using a slab FID as tracking signal was demonstrated 19 for automatic acquisition timing. However, this method didn't reflect the signal variation within the imaging slab. In this study, bolus tracking was improved by using the bolus signal from a region of interest (ROI) on a tracking image rather than from the entire excitation slab. In the context of hyperpoliarized 13 C MRI, B 1 calibration is crucial for variable flip angle schemes 15, 16, 18 and quantification of metabolic activities. 22 Due to the virtually non-existent endogenous 13 C signal, 13 C B 1 calibration is typically performed on external phantoms, but this approach does not account for the variability of subject loading. BlochSiegert B 1 mapping has been applied to hyperpolarized 13 C imaging 23, 24 and is advantageous due to its short acquisition time and efficient use of the hyperpolarization signal. However, real-time power compensation has not yet been accomplished to calibrate the flip angle during the scan. This work presents a new approach using regional bolus tracking to trigger Bloch-Siegert B 1 mapping and real-time RF power compensation based on regional B 1 measurements followed by dynamic imaging of hyperpolarized 13 C metabolites. Real-time center frequency calibration upon bolus arrival was also implemented. Thermally polarized 13 C phantom experiments were performed to validate Bloch-Siegert B 1 mapping. The feasibility of applying the proposed framework for in vivo hyperpolarized 13 C imaging was demonstrated on healthy rats, tumor-bearing mice and a healthy volunteer on a clinical 3T scanner. This proposed method was designed to improve the efficient use of the hyperpolarized signal as well as the accuracy and the robustness of hyperpolarized 13 C imaging.
| METHODS
2.1 | Real-time hyperpolarized 13 
C MRI
The proposed scheme is illustrated in Figure 1 . ROIs for both bolus tracking and B 1 calibration are prescribed according to proton anatomical images before starting 13 C sequences.
The bolus tracking sequence starts before the hyperpolarized substrate is injected. Real-time center frequency calibration based on the acquired slab frequency spectrum can be triggered upon the bolus arrival. When the peak bolus signal in the prescribed ROI is detected, Bloch-Siegert B 1 mapping is triggered and the RF power for all sequences is then calibrated in real time based on the measured ROI B 1 . The sequence triggered upon the completion of B 1 calibration for most experiments in this study is alternate pyruvate/ lactate dynamic imaging, which could be replaced by any hyperpolarized 13 C sequence for other studies. Our proposed scheme was implemented on a GE Signa MR 3T scanner (GE Healthcare, Waukesha, Wisconsin) using a commercial software (RTHawk, HeartVista, Los Altos, California) which allows for real-time reconstruction of acquired data and feedback control of the pulse sequence. The software was installed on a workstation (2.4 GHz, 16 proccessors, 64 GB RAM) running the Ubuntu operating system. The bolus tracking sequence used a singleband spectral-spatial excitation pulse and a single-shot spiral readout, similar to Figure 2 but without the Fermi pulse and associated delay. In these studies, this was used for selective imaging of [1- 13 C]pyruvate, but could be adapted for other metabolites (e.g. 13 C-urea). The algorithm for tracking the maximum bolus signal was implemented based on prior works. 14, 19 The bolus signal is the mean value of a prescribed ROI on the tracking image. to compute m noise which is converted to σ. 25 Given the noise distribution of the background in magnitude images follows a Rayleigh distribution, 25 if a probability P thr that a noise signal is above the tracking threshold is required, the proportional relationship between S thr and σ can be derived using the cumulative distribution function of a Rayleigh distribution. For example, c thr = 3 would result in a P thr of 0.001%. In the bolus tracking module, the sequence is resumed automatically if the bolus peak is not detected. When a cumulative number n cum of signal increases is detected and all these signals are above the tracking threshold as well as greater than u peak fraction of its previous signal, the program starts to update the peak value. When the bolus signal is lower than u peak fraction of the current peak signal, detection of bolus peak will be reported. In our study, u peak was determined based on estimated hypolarization loss due to T 1 . For example, under the assumptions of a T 1 of 30 s, an excitation flip angle of 5 ∘ , no more pyruvate from the bolus coming into the ROI and neglecting metabolic conversion, the hyperpolarization loss over a TR of 1s for the bolus tracking sequence would be 1-cos(5 ∘ × π/180) × exp(−1/30) = ∼0.04, and the remaining hyperpolarization (∼0.96) was used as u peak . The use of cumulative increase rather than successive increase as used in the previous work 19 aims to improve the robustness of the tracking algorithm to motion and injection with unstable rates. For some experiments, during the time that bolus signal was below the current signal peak but above u peak threshold, a short repetition time was used to shorten the time interval between actual bolus peak and detected bolus peak. The Bloch-Siegert B 1 mapping sequence 23, 24, 26 ( Figure   2 ) shared the similar excitation and readout as bolus tracking, using a singleband spectral-spatial excitation pulse and a single-shot spiral readout, whereas an off-resonance Fermi pulse (K BS = 6.76 rad/G 2 ) was inserted in between. The phase difference between two Bloch-Siegert B 1 mapping sequences with opposite ω RF was used to calculate B 1 . Taking the phase difference removes receiver phase and minimizes the influence of B 0 off-resonance frequency. 26 Parameters used in this study were designed to measure a maximum B 1 of 0.48G. The two phase maps were masked based on corresponding magnitude images in order to eliminate noisy phases due to low signal. The threshold is determined as S B 1 = c B 1 , where c B 1 is a scaling factor and noise standard deviation σ was obtained from the bolus tracking sequence. The ratio of the desired B 1 to the measured ROI B 1 was passed to all sequences as a scaling factor to calibrate transmit power in real time.
The center frequency calibration sequence consists of a sinc excitation pulse with slab selection gradient and a 102 ms readout with a 5kHz bandwidth. The acquired spectrum is used to calibrate center frequency for all sequences in real time. Alternate pyruvate and lactate dynamic imaging shared the same excitation and readout as bolus tracking, using a singleband spectral-spatial excitation pulse and a single-shot spiral readout, but with alternating excitation frequencies and different flip angles to image pyruvate and lactate.
All methods described are available through the HeartVista research collaboration portal (https://www.heartvista.com/ git/shuyu/hv_research_shuyu).
| Phantom and animal experiments
Validations of the Bloch-Siegert B 1 mapping sequence were performed on a 13 to test our proposed scheme using normal Sprague-Dawley rats and transgenic adenocarcinoma of mouse prostate (TRAMP) mice with 13 C/ 1 H birdcage coils (8 cm diameter for rats, 5 cm diameter for mice). Two experiments were also performed on a rat with a 13 C figure-8 transceiver coil.
A total of six rats and two TRAMP mice were used to test the proposed scheme. All animal studies were conducted under protocols approved by All animal experiments were performed using the proposed scheme (Figure 1 ). 13 C sequence parameters for animal experiments are shown in Table 1 . Some experiments were performed with real-time center frequency calibration. For rat experiments using the 13 C/ 1 H birdcage coil, an anatomical localizer was acquired using proton 3D bSSFP sequence (FOV 16 × 8 × 4.8 cm, Matrix size 256 × 256 × 76). A total number of five injections were performed on three rats using the proposed scheme with different combinations of injection times (8 s, 12 s) and transmit gains (100%, 120% of pre-scan power calibration). Real-time center frequency calibration were not performed in these studies. A 13 C urea phantom was used for frequency and pre-scan power calibrations. 13 C images were acquired on the axial kidney plane.
ROIs for bolus tracking and B 1 calibration were both placed on the left kidney.
For rat experiments using the 13 C transceiver coil, an anatomical localizer was acquired using proton T2-weighted fast spin echo sequence (FOV 6 × 6 cm, Matrix size 256 × 256) with the scanner body coil. The rat was positioned in a way that right kidney was about 1 cm further than left kidney from the bottom 13 C transceiver coil. This set up was designed to produce a distinct B 1 variation between two kidneys. Two injections were performed using the proposed scheme with the same parameters but with different tracking/B 1 calibrating ROIs, one on right kidney and the other on left kidney. A 13 C urea phantom embedded on the coil was used for prescan frequency calibration. Real-time center frequency calibration was performed at the bolus arrival. 13 C images were acquired on the axial kidney planes with an injection time of 10 s and transmit gain set based on pre-scan with the 13 C-urea phantom. For the TRAMP experiment, an anatomical localizer was acquired using proton T2-weighted fast spin echo sequence (FOV 6 × 6 cm, Matrix size 256 × 256). Real-time center frequency calibration was performed at the bolus arrival. 13 C images were acquired on the axial tumor plane with an injection time of 12s and transmit gain the same as the calibrated power in pre-scan. A 13 C urea phantom was used for pre-scan frequency and power calibration. ROIs for bolus tracking and B 1 calibration were both in the tumor.
| Volunteer study
One human study was performed to test the proposed scheme ( Figure 1) . A healthy volunteer was recruited with institutional review board approval and provided with written informed consent for participation in the study. The volunteer was a 37-year-old male. An Investigational New Drug approval was obtained from the U.S. Food and Drug Administration for generating the agent and implementing the clinical protocol. 1.47 g of Good Manufacturing Practices (GMP) [1-
T A B L E 1 13 C sequence parameters for animal experiments shown in Figure 4 ("Rat/Birdcage"), Figure 5 ("TRAMP") and Figure 6 ("Rat/ pyruvate (Sigma Aldrich, St. Louis, Missouri) mixed with 15 mM electron paramagnetic agent (EPA) (AH111501, GE Healthcare, Oslo, Norway) was polarized using a 5T SPINlab polarizer (General Electric, Niskayuna, New York) for 3 h before being rapidly dissolved with 130 ∘ C water and forced through a filter that removed EPA. The solution was then collected in a receiver vessel and neutralized with NaOH and Tris buffer. The receive assembly that accommodates quality-control processes provided rapid measurements of pH, pyruvate and EPA concentrations, polarization, and temperature. In parallel, the hyperpolarized solution was pulled into a syringe (Medrad Inc, Warrendale, Pennsylvania) through a 0.5 μm sterile filter (ZenPure, Manassas, Virginia) and transported into the scanner for injection. The integrity of this filter was tested in agreement with manufacturer specifications prior to injection. A 0.43 mL/kg dose of ∼250 mM pyruvate was injected at a rate of 5 mL/s via an intra-venous catheter placed in the antecubital vein, followed by a 20 mL saline flush.
In this study, 13 Table 2 .
For the online reconstruction, multichannel k-space data were combined using sum of squares. In the offline processing, coil combination was performed by using pyruvate signals as coil sensivitiy maps. 31 
| RESULTS

Axial thermal
13 C B 1 maps of the 13 C/ 1 H birdcarge coil at 50, 75, 100 and 150% of the calibrated transmit power are shown in Figure 3A . The mean B 1 value of the phantom region versus the relative transmit power is plotted ( Figure 3B ) to demonstrate the quadratic relationship between Bloch-Siegert phase difference and transmit power. A comparison between the magnitude image of nominal 180 ∘ excitation and its corresponding B 1 map of a thermal 13 C phantom on the 13 C transceiver coil is shown in Figure 3C and D. The B 1 value along the dark band in Figure 3C and its corresponding theoretical excitation flip angle (0.3 G) is plotted in Figure 3E , demonstrating the accuracy of Bloch-Siegert B 1 mapping.
Results of a representative hyperpolarized [1-13 C]pyruvate experiment using the proposed scheme to image the kidneys of a healthy rat with 13 C/ 1 H birdcage coil are shown in Figure 4 . Real-time center frequency calibration was not performed in this study. Figure 4D displays every other timeframe of the real-time reconstructed data where magnitude images are normalized by the peak value of the corresponding metabolic series. The full set of images can be found in Supporting Information Figure S1 . The acquired B 1 map ( Figure 4B ) was homogenous, as expected for this coil. The initial transmit power was purposely set to 120% of the power calibrated on a thermal 13 C phantom and resulted in a nominal B 1 scaling factor of 0.83 (1/1.2), which was in reasonable agreement with the real-time computed B 1 scaling factor of ∼0.87. Normalized pyruvate signal curves combining the data of bolus tracking and pyruvate/lactate dynamic imaging are shown in Figure 4C for different ROIs. These pyruvate signal curves demonstrate that the ROI (left kidney) bolus peak was successfully detected, and acquisition timing would be different if the tracking ROI was on the major vessels.
Sequence Parameters
Bolus Tracking 
F I G U R E 4 Results of a hyperpolarized [1-
13 C]pyruvate study in a normal rat using the proposed method ( Figure 1 ) with a birdcage coil.
Real-time center frequency calibration was not performed in this study. The ROI for both bolus tracking and B 1 calibration was on the left kidney. Injection time was 8 s and initial power was purposely set to 120% of the calibrated power in pre-scan. Sequence parameters are presented in Table  1 Results of a hyperpolarized [1- 13 C]pyruvate experiment using the proposed scheme to image the tumor of a TRAMP mouse with 13 C/ 1 H birdcage coil are shown in Figure 5 . Figure 5E displays every other timeframe of the real-time reconstructed data where magnitude images are normalized by the peak value of the corresponding metabolic series. The full set of images can be found in Supporting Information Figure S2 . The frequency spectrum ( Figure 5D ) acquired from the imaging slab at the bolus arrival shows that the measured pyruvate frequency was 20 Hz downfield from the frequency calibrated based on a thermal 13 C phantom. Bolus tracking images right before and after real-time center frequency calibration in Figure 5E demonstrate that real-time center frequency calibration reduced blurring caused by off resonance reconstruction in real-time reconstructed images.
Figure 5B depicts the normalized B 1 map which is homogenous as expected for the coil. The real-time B 1 scaling factor ( Figure 5B ) was 1.05, indicating a 5% difference from the power calibrated on a thermal 13 Results of two hyperpolarized [1-13 C]pyruvate experiments using the proposed scheme to image the kidneys of healthy rats with one-sided 13 C surface transceiver coil are shown in Figure 6 . Two experiments were performed with the same parameters but with the different tracking/calibrating ROIs, one on the right and the other on the left kidney, where the left kidney was closer to the coil. B 1 maps ( Figure  6B ) acquired in two experiments are consistent and show that the left kidney experienced a 40% higher B 1 than the right kidney did. This agreed with the real-time B 1 scaling factors, 1.49 and 1.07 for the tracking experiments on the left and right kidney, respectively. k PL maps fitted with and without flip angle correction for the two experiments are shown in Figure 6C , where k PL values of right kidney, left kidney and intestine are labeled. Root mean squared errors of k PL values in the three labeled ROIs between two experiments are 0.0033 with flip angle correction and 0.0045 without flip angle correction, demonstrating that using acquired
F I G U R E 5 Results of a hyperpolarized [1-
13 C]pyruvate study in a TRAMP mouse using the proposed method ( Figure 1 ) with a birdcage coil.
The ROI for both bolus tracking and B 1 calibration was the tumor. Injection time was 12 s and initial power was the same as the calibrated power in pre-scan. Sequence parameters are presented in Table 1 Figure 7C ) acquired from slice 5 upon the bolus arrival shows that the measured pyruvate frequency was the same as the frequency calibrated in pre-scan. Figure  7B depicts the normalized B 1 map which is homogenous as expected for the birdcage transmit coil. The real-time B 1 scaling factor ( Figure 7B ) was ∼1.04, 4% difference from the power calibrated in pre-scan. Pyruvate, lactate and bicarbonate sum-over-time images are displayed in Figure 8 , where maximum SNRs for pyruvate, lactate and bicarbonate are 627, 60 and 20, respectively. Dynamic images can be found in Supporting Information Figure S3 . Experiment recordings are provided on (see links in the figure) to demonstrate real-time actions during the experiments.
| DISCUSSION
As discussed in the Introduction section, automatic acquisition timing via bolus tracking improves efficient use of hyperpolarization as well as consistency and accuracy of hyperpolarized 13 C imaging. Furthermore, accurate timing is critical for some optimal variable flip angle schemes and metabolic quantification. [15] [16] [17] [18] The implementation of regional bolus tracking in this work improves the flexibility and accuracy of acquisition timing, and it would be especially useful for imaging tissue with low perfusion rate where injected metabolites would arrive at the target region later relative to major vessels or other tissues. The resolution of the bolus tracking image should be chosen as coarse as possible to improve image SNR but fine enough to separate the desired tracking region (e.g. major vessels from other tissues). An alternative approach is to use 2D spatially selective excitation pulses, but this approach is less robust to signals from off-resonance metabolites. In this study, bolus tracking triggered its following sequences either upon bolus arrival or following peak detection. This could easily be modified to use other schemes, such as starting metabolic imaging during the bolus or adding an additional delay from the peak.
F I G U R E 6
Results of two hyperpolarized [1-
13 C]pyruvate studies in a normal rat using the proposed method ( Figure 1 ) with a
13
C surface transceiver coil. The two experiments were performed with the same parameters except for different tracking/calibrating ROIs: experiment #1 on right kidney and #2 was on left kidney, where the left kidney is closer to the coil. Injection time was 10 s and initial power was the same as the calibrated power in pre-scan. Sequence parameters are presented in Table 1 
F I G U R E 7 Results of hyperpolarized [1-
13 C]pyruvate studies on a healthy human volunteer using the proposed method (Figure 1 ) with inhouse built birdcage transmit coil and 32-channel receive array. In this study, single-slice real-time B 1 calibration was triggered right after real-time center frequency calibration. The ROI for both bolus tracking and B 1 calibration was on the brain tissue near the superior sagittal sinus of slice 5 (see Figure 8 for slice [1] [2] [3] [4] [5] [6] [7] [8] . A multi-slice 2D acquisition was used for pyruvate/lactate/bicarbonate dynamic imaging. Initial power was the same as the calibrated power in pre-scan. Sequence parameters are presented in Table 2 . Manually triggering sequences during bolus tracking is also allowed in the designed framework and is useful if the automatic tracking algorithm fails. The bolus tracking used a flip angle of 5 ∘ and a TR of 1 s. Assuming an injection time of 10 s, the expected total hyperpolarized signal loss due to bolus tracking RF pulses would be less than 2%. The naturally low-abundance 13 Figure 6 ). Real-time B 1 calibration could achieve accurate flip angle during the scan, which is critical for variable flip angle schemes [15] [16] [17] [18] and large flip angle pulses, 33 and avoiding unnecessary use of hyperpolarization. The upper limit of the B 1 measurement depends on the K BS value of the Bloch-Siegert pulse while the lower limit depends on the SNR. 2D phase unwrapping could be implemented in real time to extend the upper limit of B 1 measurement. Real-time masking of the acquired B 1 map based on signal intensity made the real-time B 1 calibration robust when the B 1 calibration ROI contained regions with low hyperpolarized signal. The two TRs required for the B1 mapping sequence used a pyruvate flip angle of 10 ∘ , using only 3% of the hyperpolarization magnetization. Center frequency calibration is crucial for metabolite specific imaging. For singleband spetral-spatial pulses, frequency calibration errors will reduce the flip angle and may also excite undesired resonances. For spiral or echo-planar imaging (EPI) readouts, frequency calibration errors will lead to off-resonance blurring and shift artifacts. Both of these factors can undermine the accuracy of Bloch-Siegert B1 mapping and quantification of metabolism. Using a thermal 13 C phantom, which must be placed external to the subject, center frequency calibration doesn't capture B 0 within the subject. Although B 0 maps can be obtained via proton imaging, in vivo shimming could still be challenging, particularly in the presence of motion. In this study, real-time center frequency was triggered upon bolus arrival, which improved the quality of all the following real-time reconstructed images ( Figure 5E ). The 102 ms readout duration of the center frequency measurement sequence resulted in a ∼10 Hz frequency resolution which could be improved with a longer readout duration. A 3 ∘ flip angle cost less than 0.2% hyperpolarization.
The transition time between acquisitions is mainly attributed to real-time image reconstruction and loading sequence waveforms. For animal experiments using single-channel acquisition, the transition times of a bolus tracking acquisition, real-time center frequency calibration, real-time B 1 calibration and their following sequences were about 60 ms, 60 ms and 400 ms, respectively. For the human experiment using 32-channel acquisition, a longer transition time (∼800 ms) was observed for real-time B 1 calibration, whereas transition times for bolus tracking acquisition and real-time center frequency calibration remained similar. The longer transition time found in B 1 calibration could be caused by its more complicated reconstruction compared to frequency calibration, and its shorter TR compared to a bolus tracking acquisition which typically used a TR of 1s and allowed real-time reconstruction to be completed during the dead time of a TR.
A 13 C-pyruvate and 13 C-urea co-polarized injection 34 would benefit substantially from the proposed methods. 13 C-urea could be used to perform bolus tracking, real-time center frequency and B 1 calibration. This strategy would fully reserve hyperpolarized signal of pyruvate 19 and provide higher SNR for B 1 mapping by using a larger flip angle. Cardiac and respiratory motion could detrimentally affect bolus tracking and Bloch-Siegert B 1 mapping. Cardiac gating could be used. 23 In terms of respiratory motion, breathholding is often used in clinical studies. Respiratory gating is not suitable for bolus tracking due to large potential delays but can be applied to perform B 1 mapping at the end of exhalation, 23 in which case, a short TR (200 ms) as used in this study is recommended. A more challenging but robust approach to handle motion is to perform real-time image registration. To extend the proposed scheme for volumetric calibration, real-time center frequency and B 1 calibration can be integrated with a multislice imaging framework. 23 More than one ROI for tracking or B 1 calibration could be useful when B 1 (e.g. Figure 6B ) or acquisition timing (e.g. Figure  4C ) shows variation within the imaging subject.
| CONCLUSION
This work demonstrated an approach that integrates automatic acquisition timing using the regional bolus signal with real-time center frequency calibration, Bloch-Siegert B 1 mapping and real-time RF power compensation based on regional B 1 measurements as well as dynamic hyperpolarized 13 C imaging. This scheme allows for timing the acquisition based on bolus information of a local region within the imaging plane. Acquiring in vivo B 1 maps, performing real-time center frequency calibration and B 1 calibration, ensures accurate center frequency and flip angles which are used in the following hyperpolarized 13 C sequences. The proposed scheme was successfully demonstrated for in vivo hyperpolarized [1-13 C]pyruvate imaging on a clinical 3T scanner. Future work will focus on incoporating pyruvate-urea co-polarized injections, volumetric calibration and motion-compensation methods into the proposed scheme to improve efficiency, accuracy, and robustness of hyperpolarized 13 C studies.
| TANG eT al.
SUPPORTING INFORMATION
Additional supporting information may be found online in the Supporting Information section at the end of the article.
FIGURE S1
Results of bolus tracking and pyruvate/lactate dynamic imaging of the experiment described in Figure 4 . Figure 4 shows every other 13 C image in this figure.
FIGURE S2
Results of bolus tracking and pyruvate/lactate dynamic imaging of the experiment described in Figure 5 . Figure 5 shows every other 13 C image in this figure.
FIGURE S3 Sum of first twenty time points of multi-slice pyruvate/lactate/bicarbonate dynamic images as shown in Figure 7 . 
